Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma.
about
Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cellsDevelopmental context determines latency of MYC-induced tumorigenesisGenome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, ChinaLoss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis.Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma.Identification of hepatocarcinogen-resistance genes in DBA/2 mice.Interaction of Hepatitis B virus with cellular processes in liver carcinogenesis.Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1.The cooperative effect of p53 and Rb in local nanotherapy in a rabbit VX2 model of hepatocellular carcinoma.Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infectionHepatitis B virus infection and primary hepatocellular carcinoma.Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosisNonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver.Genetic control of susceptibility to diethylnitrosamine and dimethylbenzanthracene carcinogenesis in rats.Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17pLoss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization.Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesisHepatitis B virus transactivator X protein is not tumorigenic in transgenic miceX rays induce interallelic homologous recombination at the human thymidine kinase gene.Evidence for increased in vitro recombination with insertion of human hepatitis B virus DNAAbsence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma.A mortality gene(s) for the human adenocarcinoma line HeLa maps to a 130-kb region of human chromosome 4q22-q23Functional evidence for a squamous cell carcinoma mortality gene(s) on human chromosome 4.Overexpression of SMARCA5 correlates with cell proliferation and migration in breast cancer.The role of hepatitis B virus in development of primary hepatocellular carcinoma: Part II.Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis.The molecular pathogenesis of hepatocellular carcinoma.Genomic instability in 1p and human malignancies.Primary liver cancer is of multifactorial origin: importance of hepatitis B virus infection and dietary aflatoxin.Molecular mechanism of hepatocarcinogenesis.Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade--results of an explorative CGH meta-analysis.Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.Allelotype analysis of adenocarcinoma of the gastric cardia.Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13qDiminished expression of phosphatidylethanolamine N-methyltransferase 2 during hepatocarcinogenesis.Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma.Genetic changes and histopathological grades in human hepatocellular carcinomas.Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas.Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
P2860
Q24656941-A2A1E46A-0158-4313-A25E-B388CA684C35Q24794847-9373CCDA-B394-4C52-86DE-1F926CCA623EQ28538135-8A6B4A8E-1985-405B-BEA9-5E1D8A1A493EQ30486880-4D8F19D8-CBE2-4165-AAD5-2C41C615493DQ33772796-9E472C69-828F-4EDD-8749-9CF0AEFF0EF2Q33964289-BA911A17-5840-4068-8A4C-B94285342E4AQ34082379-EC42BE72-E1E9-41CC-9B90-C27AFB489C22Q34136464-56727330-7E42-473D-A216-54E6F9363280Q35016771-50B38C21-3FC3-4076-8C6E-78859C3BDC4DQ35196962-6D9F8F3F-A282-41DD-853F-B3BFE42D5733Q35231554-3065E6C8-8418-4F3E-B00B-9C9D0512F2C4Q35754634-B0181F1A-0B97-4A34-A269-0A4F0C9DFBC3Q35786754-7FEF1D4F-36C4-4AF9-89F1-7FE8A23F6FEBQ35830580-992FD236-8722-4F3F-97D9-53E57587DF31Q36419914-EF1A77F0-5C81-4B21-8C10-BF8879D4F318Q36617917-869A0A27-CE0C-4A55-BEFC-F53011524669Q36620680-42E60B46-2D9B-4AA6-A33D-E44C1EEB28F3Q36623649-2F76A705-D27A-4A83-8FE6-D254F2F7692CQ36796019-8210BAF3-0E4A-4E09-BB01-FE93E835633BQ36817436-8642252F-7EED-471F-893D-8684682C54EEQ37608976-F6BAFD54-8560-4E99-8AFC-9633635E7B93Q38322780-B7C52D63-B2C6-4379-AF13-87312DB7DABBQ38487020-3FD43F56-DD91-4E12-86C9-071ABB7E012CQ38488166-51903F25-304C-41E0-848D-C9D9722E4291Q38942137-0DC620C7-FBAE-45E9-A905-FB7F32D4B298Q40851672-27FCB0C2-2019-414D-AC92-7A3E07167309Q41051463-2885B29B-FB6A-42F0-B42D-F3F1F0BA1532Q41098848-741B6BE9-89A6-4EDA-8608-507C4BD1AF6DQ41170258-BD9AC6E0-E0E8-42B4-AB93-1335B6C6B722Q41267173-57430513-DD87-485A-B43C-4CEBF4C68497Q41667327-D3A0E277-5F9E-40D8-937F-48B236867EF1Q41886998-9B482C70-BC98-4F0E-8E86-53BEADE09504Q41910235-C64B52D2-E1AF-4D85-ACAA-83DBD70BCE2DQ41931838-7C7929E6-5A0E-4471-87DB-662F2D54E0DDQ42098220-374D2BBB-1D9A-471C-AF98-E9E7291AD646Q42992392-F4E4C385-C906-4EE9-A751-9B1717AAEFE4Q43037073-EF2ED9FF-32E0-4F4D-8D9C-D2E7D9D69EE2Q45267872-D5616FA6-D848-4024-AF1D-19EAF4D8071CQ45739975-030CFA8D-2E43-4465-AE9F-67323B9A4660Q45740459-16E066C9-C400-4B83-A0EF-108235E6F3C7
P2860
Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma.
description
1989 nî lūn-bûn
@nan
1989 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Loss of heterozygosity suggest ...... mary hepatocellular carcinoma.
@ast
Loss of heterozygosity suggest ...... mary hepatocellular carcinoma.
@en
Loss of heterozygosity suggest ...... mary hepatocellular carcinoma.
@nl
type
label
Loss of heterozygosity suggest ...... mary hepatocellular carcinoma.
@ast
Loss of heterozygosity suggest ...... mary hepatocellular carcinoma.
@en
Loss of heterozygosity suggest ...... mary hepatocellular carcinoma.
@nl
prefLabel
Loss of heterozygosity suggest ...... mary hepatocellular carcinoma.
@ast
Loss of heterozygosity suggest ...... mary hepatocellular carcinoma.
@en
Loss of heterozygosity suggest ...... mary hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1476
Loss of heterozygosity suggest ...... mary hepatocellular carcinoma.
@en
P2093
J C Murray
J L Israel
K H Buetow
S Govindarajah
V Blanquet
W T London
P2860
P304
P356
10.1073/PNAS.86.22.8852
P407
P577
1989-11-01T00:00:00Z